Popular topics to explore
APOLLOHOSP
Apollo Hospitals delivered a strong dose of growth this quarter — not just for patients, but for investors too.
💊 Sales: ₹5,842 Cr — +15% YoY on the back of higher patient footfall, expanding service offerings, and steady growth in specialized care.
💉 EBIDT: ₹852 Cr — +26% YoY, reflecting improved operational efficiency and better cost control.
❤️ Net Profit: ₹441 Cr — +42% YoY, a robust jump as margins expand.
📊 EPS: ₹30.10 vs ₹21.23 last year — also +42% YoY, strengthening investor confidence.
Our view:
Apollo is firing on all cylinders — strong revenue growth, higher profitability, and margin improvement. With rising demand for healthcare services and Apollo’s brand strength, the runway for growth remains healthy.
Disclaimer: This is an educational & informational post, not investment advice.#WatchOutFor#FundamentalViews#StockInNews#EquityResearch#MacroViews
1,145 likes·43 comments

















